Insight into the Contrasting Findings of Therapeutic Trials of Digital Ischaemic Manifestations of Systemic Sclerosis John D. PaulingVivek NagarajaDinesh Khanna Scleroderma (C Denton, Section Editor) 27 February 2019 Pages: 85 - 103
Treatment of Diffuse Cutaneous Systemic Sclerosis with Biologics, Small Molecules and Stem Cell Transplantation: What Is the Evidence to Date? Brigit KerstenMadelon Vonk Scleroderma (C Denton, Section Editor) Open access 26 February 2019 Pages: 104 - 114
Guidelines and Recommendations Towards Evidence-Based Management of Systemic Sclerosis Sindhu R. JohnsonKeshini Devakandan Scleroderma (C Denton, Section Editor) 22 April 2019 Pages: 115 - 126
Interstitial Lung Disease in Systemic Sclerosis: Lessons Learned from Idiopathic Pulmonary Fibrosis Augustine ChungJames EnglishElizabeth R. Volkmann Scleroderma (C Denton, Section Editor) 12 April 2019 Pages: 127 - 146
Challenges and Advances in SLE Autoantibody Detection and Interpretation May Y. ChoiMarvin J. Fritzler Lupus (S Keeling, Section Editor) Open access 07 May 2019 Pages: 147 - 167
Self-Efficacy and the Role of Non-pharmacologic Treatment Strategies to Improve Pain and Affect in Arthritis Dana DiRenzoPatrick Finan Pain (W Nielson, Section Editor) 30 April 2019 Pages: 168 - 178